Human ovarian cancer cell lines resistant to cisplatin, doxorubicin, and l-phenylalanine mustard are sensitive to Δ7-prostaglandin Δ1 and Δ12-prostaglandin J2

This publication has 9 references indexed in Scilit:

• Effect of Glutathione on DNA Repair in Cisplatin-Resistant Human Ovarian Cancer Cell Lines
  JNCI Journal of the National Cancer Institute, 1989
• Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletion
  Chemico-Biological Interactions, 1988
• Adriamycin accumulation and metabolism in adriamycin-sensitive and -resistant human ovarian cancer cell lines
  Biochemical Pharmacology, 1986
• Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion
  Biochemical Pharmacology, 1985
• Reversal of Adriamycin Resistance by Verapamil in Human Ovarian Cancer
  Science, 1984
• Growth responses of rat stomach cancer cells to gastro‐entero‐pancreatic hormones
  International Journal of Cancer, 1982
• Reduction in glutathione content of L-PAM resistant L1210 cells confers drug sensitivity
  Biochemical Pharmacology, 1982
• Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues
  Analytical Biochemistry, 1969
• Tissue sulfhydryl groups
  Archives of Biochemistry and Biophysics, 1959